Incidence and Risk of Pneumococcal Pneumonia in Adults with Distinct Underlying Medical Conditions: A Population-Based Study
- 6 April 2020
- journal article
- research article
- Published by Springer Nature in Lung
- Vol. 198 (3) , 481-489
Abstract
Purpose This study investigated the incidence of pneumococcal pneumonia requiring hospitalisation among middle-aged and older adults with and without specific underlying medical conditions, evaluating the influence of these conditions in the risk of developing pneumonia. Methods Population-based prospective cohort study included 2,025,730 individuals ≥ 50 years around Catalonia, Spain. The Catalonian information system for the development of research in primary care (SIDIAP) was used to establish baseline characteristics of the cohort (comorbidities and underlying medical conditions). Hospitalisations from pneumococcal pneumonia occurred among cohort members between 01/01/2015 and 31/12/2015 were collected from hospital discharge codes of 68 reference Catalonian hospitals. Cox regression was used to estimate the association between baseline conditions and the risk of developing pneumonia. Results Global incidence rate (IR) of hospitalised pneumococcal pneumonia was 82.8 cases per 100,000 persons-year. Maximum IRs (per 100,000 persons-year) emerged among persons with haematological neoplasia (837.4), immunodeficiency (709.2), HIV infection (474.7), severe renal disease (407.5) and chronic pulmonary disease (305.7). In the multivariable analyses, apart from increasing age, HIV infection (hazard ratio [HR] 6.78), haematological neoplasia (HR 6.30), prior all-cause pneumonia (HR 5.27), immunodeficiency (HR 4.57) and chronic pulmonary disease (HR 2.89) were the conditions most strongly associated with an increasing risk. Pneumococcal vaccination did not emerge associated with a reduced risk in our study population (nor PPsV23 neither PCV13). Conclusion Old age, immunocompromising conditions and chronic pulmonary/respiratory disease are major risk factors for pneumococcal pneumonia in adults. Our data underline the need for better prevention strategies in these persons.Keywords
Funding Information
- Instituto de Salud Carlos III (PI15/01230)
This publication has 20 references indexed in Scilit:
- Pneumococcal infection in adults: burden of diseaseClinical Microbiology and Infection, 2014
- Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic TechniquesPLOS ONE, 2013
- The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2012
- Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccinesCurrent Opinion in Pulmonary Medicine, 2010
- Pathogenesis, treatment, and prevention of pneumococcal pneumoniaThe Lancet, 2009
- Streptococcus pneumoniae: Epidemiology, Risk Factors, and Clinical FeaturesSeminars in Respiratory and Critical Care Medicine, 2005
- The Influence of Chronic Illnesses on the Incidence of Invasive Pneumococcal Disease in AdultsThe Journal of Infectious Diseases, 2005
- Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation studyThorax, 2003
- Applied Survival Analysis: Regression Modeling of Time to Event DataJournal of the American Statistical Association, 2000
- The burden of pneumococcal disease among adults in developed and developing countries: what is and is not knownVaccine, 1999